PMID- 30937319 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220408 IS - 2325-9671 (Print) IS - 2325-9671 (Electronic) IS - 2325-9671 (Linking) VI - 7 IP - 3 DP - 2019 Mar TI - Primary Hip Arthroscopic Surgery With Labral Reconstruction: Is There a Difference Between an Autograft and Allograft? PG - 2325967119833715 LID - 10.1177/2325967119833715 [doi] LID - 2325967119833715 AB - BACKGROUND: Labral reconstruction has been described as a solution for the irreparable labrum. Initial techniques employed autografts, while more recent procedures have utilized allografts. No study, to our knowledge, has compared graft types. PURPOSE: To compare outcomes between patients who underwent primary labral reconstruction with a hamstring allograft versus hamstring autograft. HYPOTHESIS: No significant differences in outcomes will be found between patients who underwent primary labral reconstruction with an allograft versus autograft. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Data from September 2010 to March 2015 were reviewed. Inclusion criteria were primary hip arthroscopic surgery with labral reconstruction using either a hamstring allograft (ALLO group) or autograft (AUTO group), with minimum 2-year follow-up scores for the modified Harris Hip Score (mHHS), Non-Arthritic Hip Score (NAHS), Hip Outcome Score-Sports-Specific Subscale (HOS-SSS), and visual analog scale (VAS) for pain. Exclusion criteria were previous ipsilateral hip surgery, previous hip conditions, preoperative Tonnis osteoarthritis grade >1, and workers' compensation claims. Significance was set at P = .05. RESULTS: Twenty-nine patients (29 hips) were included (85.3% follow-up). There were 17 patients (17 hips) in the ALLO group and 12 patients (12 hips) in the AUTO group. All patient-reported outcome scores demonstrated significant improvements at latest follow-up except for the mHHS for the AUTO group (P = .064). Comparisons between the ALLO and AUTO groups at the preoperative and latest follow-up time points showed no significant differences (preoperative mean [range]: mHHS, 67.5 [33.0-100.0] and 65.8 [29.0-96.0], respectively [P = .826]; NAHS, 65.6 [26.3-92.5] and 58.5 [35.0-79.0], respectively [P = .322]; HOS-SSS, 43.7 [12.5-100.0] and 40.1 [19.0-78.0], respectively [P = .707]) (latest follow-up mean [range]: mHHS, 86.4 [56.0-100.0] and 81.4 [57.0-100.0], respectively [P = .46]; NAHS, 87.7 [60.0-100.0] and 82.4 [56.3-100.0], respectively [P = .396]; HOS-SSS, 81.7 [0.0-100.0] and 70.9 [27.8-100.0], respectively [P = .423]). CONCLUSION: Primary arthroscopic hip labral reconstruction yielded improvements in patient-reported outcome scores and high patient satisfaction. In this small series, no differences were found in clinical outcomes between hamstring allografts and autografts. Based on these results, hamstring allografts and autografts may be considered comparable graft choices for primary reconstruction. Because of the avoidance of donor site morbidity and the possible increase in patient satisfaction, allografts may be the preferred choice in a surgical setting when they are accessible. FAU - Maldonado, David R AU - Maldonado DR AD - American Hip Institute, Des Plaines, Illinois, USA. FAU - Lall, Ajay C AU - Lall AC AD - American Hip Institute, Des Plaines, Illinois, USA. FAU - Laseter, Joseph R AU - Laseter JR AD - Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. FAU - Kyin, Cynthia AU - Kyin C AD - American Hip Institute, Des Plaines, Illinois, USA. FAU - Chen, Jeffrey W AU - Chen JW AD - American Hip Institute, Des Plaines, Illinois, USA. FAU - Go, Cammille C AU - Go CC AD - American Hip Institute, Des Plaines, Illinois, USA. FAU - Domb, Benjamin G AU - Domb BG AD - American Hip Institute, Des Plaines, Illinois, USA. LA - eng PT - Journal Article DEP - 20190325 PL - United States TA - Orthop J Sports Med JT - Orthopaedic journal of sports medicine JID - 101620522 PMC - PMC6434443 OTO - NOTNLM OT - hamstring graft OT - hip arthroscopic surgery OT - labral reconstruction COIS- One or more of the authors has declared the following potential conflict of interest or source of funding: A.C.L. has received research support from Arthrex, educational support from Medwest and Smith & Nephew, and hospitality payments from Stryker. B.G.D. has ownership interests in Hinsdale Orthopaedics, the American Hip Institute, SCD#3, North Shore Surgical Suites, and Munster Specialty Surgery Center; has received research support from Arthrex, ATI, the Kauffman Foundation, and Pacira Pharmaceuticals; has received consulting fees from Adventist Hinsdale Hospital, Arthrex, MAKO Surgical, Medacta, Pacira Pharmaceuticals, and Stryker; has received educational support from Arthrex, Breg, and Medwest; has received speaking fees from Arthrex and Pacira Pharmaceuticals; and receives royalties from Arthrex, DJO Global, MAKO Surgical, Stryker, and Orthomerica. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. EDAT- 2019/04/03 06:00 MHDA- 2019/04/03 06:01 PMCR- 2019/03/25 CRDT- 2019/04/03 06:00 PHST- 2019/04/03 06:00 [entrez] PHST- 2019/04/03 06:00 [pubmed] PHST- 2019/04/03 06:01 [medline] PHST- 2019/03/25 00:00 [pmc-release] AID - 10.1177_2325967119833715 [pii] AID - 10.1177/2325967119833715 [doi] PST - epublish SO - Orthop J Sports Med. 2019 Mar 25;7(3):2325967119833715. doi: 10.1177/2325967119833715. eCollection 2019 Mar.